Lab Test

Drugs of Abuse Panel, without Confirmation

Drug Screen

Test Codes

EPIC: LAB8506

Specimen Collection Criteria

Collect: 50 mL random urine specimen in a screw-capped container (preferred) or other sterile collection container. (Minimum: 30 mL for adults, 20 mL for pediatrics)

  • See Minimum Pediatric Requirements.
  • Refrigerate the specimen immediately after collection.
  • Record the exact time of specimen collection on the container or in the computer system.

Physician Office/Draw Specimen Preparation

Maintain specimen refrigerated (2-8°C or 36-46°F) prior to transport.

Preparation for Courier Transport

Transport: 50 mL urine, refrigerated (2-8°C or 36-46°F). (Minimum: 30 mL for adults, 20 mL for pediatrics)

Rejection Criteria

  • Specimens not collected and processed as indicated.
  • Urine Vacutainer® tubes. Urine received in a glass or plastic tube with a rubber stopper may contain insufficient sample volume, preclude confirmatory testing, and give rise to contaminants and artifacts.

In-Lab Processing

Analyze specimen immediately upon receipt in the Laboratory.

Storage

Specimen Stability for Testing:

Room Temperature (20-26°C or 68-78.8°F): 72 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): 3 months

Specimen Storage in Department Prior to Disposal:

Frozen (-20°C/-4°F or below): 1 month

Laboratory

Canton Laboratory
Dearborn Chemistry Laboratory
Farmington Hills Chemistry Laboratory
Grosse Pointe Chemistry Laboratory
Royal Oak Automated Chemistry Laboratory
Taylor Chemistry Laboratory
Trenton Chemistry Laboratory
Troy Chemistry Laboratory
Wayne Chemistry Laboratory

NOTE: Screens are performed at Canton, Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Taylor, Trenton, Troy and Wayne.

Performed

Sunday – Saturday, 24 hours a day.
STAT screen results available within 1 hour of receipt in the Laboratory.

Reference Range

See specific analytes for reference ranges.

This panel includes urine screening for:
Amphetamine/Methamphetamines, Barbiturates, Benzodiazepines, Cannabinoid, Cocaine, Fentanyl, Methadone, Opiates, Oxycodone, Phencyclidine (PCP).

Test Methodology

Immunoassay. The confirmation component of this test was developed by Beaumont Health. It has not been cleared or approved by the FDA. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes and should not be regarded as investigational or for research.

Interpretation

See specific analytes for reference ranges. 

This panel includes urine screening for: 
Amphetamine/MethamphetaminesBarbituratesBenzodiazepinesCannabinoidCocaineFentanylMethadoneOpiatesOxycodonePhencyclidine (PCP).

Clinical Utility

See specific analytes for reference ranges. 

This panel includes urine screening for: 
Amphetamine/MethamphetaminesBarbituratesBenzodiazepinesCannabinoidCocaineFentanylMethadoneOpiatesOxycodonePhencyclidine (PCP).

CPT Codes

80301x8, 80326, 80345, 80347, 80349, 80353, 80358, 80364, 80375 (alternate: G0479, G0480).

Contacts

Last Updated

5/5/2021

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.